title: Neuropharmacogenetics and behavioral genetics.
abstract: Genetic studies of neurotransmitter processes to date differ from most behavioral genetic studies in that the former have rarely considered individual variability, have tended to look only for single-gene effects, and generally have overlooked or ignored environmental influences. After examining these differences, we suggest that a rapprochement between the two fields will yield synergistic benefits in studies of the genetics of neuropharmacological processes as they affect behavior.
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000201:enzymology; D004299:Dopamine beta-Hydroxylase / Q000235:genetics; D014644:Genetic Variation; D005824:Genetics, Behavioral; D006801:Humans; D001523:Mental Disorders / Q000235:genetics* / Q000523:psychology; D008967:Molecular Biology; D008995:Monoamine Oxidase / Q000235:genetics; D018377:Neurotransmitter Agents / Q000378:metabolism*; D010641:Phenotype; D010625:Phenylethanolamine N-Methyltransferase / Q000235:genetics; D012106:Research; D012931:Social Environment; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics
chemical_list: D018377:Neurotransmitter Agents; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D008995:Monoamine Oxidase; D010625:Phenylethanolamine N-Methyltransferase